As the legalization of medical cannabis continues to strike controversy around the U.S., many may not realize the medical benefits of its usage. Dr. Rana R. Zeine is an expert in pathology and neuropathology with over three decades of experience in experimental medicine. Her research explores the largely unstudied benefits of medical cannabis in treating a variety of ailments such as epilepsy, multiple sclerosis, cancer, Parkinson's, and others. In this blog post, read as Dr. Zeine provides insightful analyses of the themes featured in these books and how they relate to the usage of medical cannabis as a form of treatment for concussions. Please read her insights below.
Hear From the Editor
“This book distinguishes itself from other books on cannabis by combining the scientific knowledge and reviewing the clinical evidence available from countries around the world on the medical effects of cannabinoids and cannabimimetics. It compiles the perspectives of doctors and scientists who have been actively focusing on this underrepresented area of research at multiple academic institutions over the last two decades. The comprehensive list of references is a uniquely valuable resource for doctors, researchers, students, journalists, investors, and policy makers.”
- Dr. Rana Zeine, Kean University
Books on Concussion Treatment
Description of the Chapter
This chapter describes what chronic traumatic encephalopathy (CTE) is and its impact on the field of professional sports. An analysis of the current CTE epidemic is explored as well as ethical concerns of this phenomena. This research provides an in-depth discussion valuable for anyone interested in the medical field and its relation to sports.
Insights from Dr. Rana R. Zeine
“Based on the presentation in chapter 31, where Dino Sossi, of Columbia University, discusses the magnitude of investments in the sports industry, the enormous revenues derived from organized sports, and the financial legal and healthcare costs of the long-term consequences of repetitive brain trauma in athletes, including Chronic Traumatic Encephalopathy (CTE), it is vital to promote and fund future research for prevention and treatment of post-concussive injuries.”
- Dr. Rana Zeine, Kean University
Description of the Chapter
This chapter explores rehabilitation processes and how patients can take initiative to boost their recovery. Discussing future implications of these recovery models, this chapter provides a dynamic perspective on boosting healing processes for a number of ailments. The case study featured in this chapter is a prime resource for a variety of readers.
Insights from Dr. Rana R. Zeine
“In chapter 3, Morris and Ye discuss the importance of physical education in rehabilitation programs to accelerate recovery of health and activity after injuries. Physical therapy, education, and counseling will prove particularly helpful in supporting athletes and military personnel to maintain their well-being since they are exposed to repetitive concussive head injuries increasing their risk of developing irreversible brain damage culminating in chronic traumatic encephalopathy (CTE). Indeed, managing CTE is a complex challenge that requires a multidisciplinary approach encompassing neurological, psychiatric, rehabilitative and novel pharmacologic interventions including medical cannabis (reviewed in Aryee et al. 2024 https://doi.org/10.52338/conr.2024.4088) ”
- Dr. Rana Zeine, Kean University
Description of the Chapter
This chapter explores the usage of dietary supplements to support active individuals. As dietary supplements continue to spike in popularity, this chapter offers valuable insights on the positive and negative effects of utilizing dietary supplements. Full of practical knowledge, this book is ideal for anyone interested in health and wellness.
Insights from Dr. Rana R. Zeine
“In chapter 1, Banerjee et al. discuss the safety and efficacy of dietary supplements, vitamins, minerals and amino acids, in the context of enhancing athletic performance. Future studies are warranted to investigate any interactions between medical cannabis and these dietary supplements since medical cannabis holds great promise in orthopedic and sports medicine strategies for accelerating tissue repair and providing anti-anxiolytic and analgesic effects.”
- Dr. Rana Zeine, Kean University
Additional Remarks from Dr. Rana R. Zeine
“Repetitive traumatic brain injury (rTBI) affects children, adolescents, and young adults. If not addressed, it leads to an accumulation of neuropathologic lesions as in accelerated aging with the development of chronic traumatic encephalopathy (CTE) in mid-life. Clinical manifestation of CTE may include, dementia, seizures, and a variety of neuropsychiatric disorders. The criteria for neuropathologic staging of CTE have been refined and include lesions found in taupathies such as Alzheimer's dementia, synucleinopathies such as Parkinson's disease, neuroinflammation and demyelination such as in Multiple Sclerosis (reviewed in Aryee et al. 2024). Our book on medical cannabis includes chapters on neurodegeneration, neuroinflammation, and demyelination, discussing the mechanisms of medical cannabis in neuroregeneration, remyelination, anti-seizure, and anti-inflammatory effects (Zeine & Teasdale, IGI Global 2023). Medical cannabis should therefore be investigated as a promising tool in the fight against the progression from rTBI to CTE.”
- Dr. Rana Zeine, Kean University
About the Editor
Rana R. Zeine MD, PhD, MBA is adjunct faculty at Kean University and visiting professor at Chamberlain University College of Nursing, teaching Neuroscience, Anatomy, Physiology, Immunology, Biology of Cancer, Biological Aspects of Aging, and Microbiology. She was associate professor of Pathology at the Saint James School of Medicine. She earned her BS in Biology, Teaching Diploma and MD degrees from the American University of Beirut with elective rotations in neuropediatrics at Massachusetts General Hospital and Boston Children's Hospital, Harvard Medical. Her PhD from McGill University focused on cancer, autoimmunity and neuroimunology. She was research associate for multiple sclerosis at the University of Ottawa and Albert Einstein College of Medicine where she completed residency in pathology and fellowship in neuropathology (2004) at Montefiore Medical Center, Bronx, NY. She was research scientist for dementia at Nathan Kline Institute, and research faculty for neuroblastoma at Northwestern Univ. and the University of Chicago. Dr. Zeine earned an MBA with Distinction (2012) from Keller Graduate School of Management and is accredited in organizational culture & effectiveness from Human Synergistics International.
Disclaimer: The opinions expressed in this article are the author’s own and do not reflect the views of IGI Global Scientific Publishing.
Browse for more posts in:
Medical, Healthcare, and Life SciencesMedical, Healthcare, & Life SciencesPharmacologyBooks & E-Books